Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastroesophageal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03277352
What this trial is testing

INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 10
Testing effectiveness (Phase 2)UnknownNCT03939962
What this trial is testing

Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma

Who this might be right for
Gastric Cancer
Henan Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03126110
What this trial is testing

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 145
Testing effectiveness (Phase 2)Looking for participantsNCT04840264
What this trial is testing

Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction

Who this might be right for
Metastatic Gastric AdenocarcinomaMetastatic Gastroesophageal Junction AdenocarcinomaPeritoneal Carcinomatosis
Sixth Affiliated Hospital, Sun Yat-sen University 79
Not applicableEnded earlyNCT02988934
What this trial is testing

The WATS3D (Wide Area Transepithelial Sample Biopsy With 3-Dimensional Computer-Assisted Analysis) U.S. Registry

Who this might be right for
Barrett EsophagusGastroesophageal RefluxEsophageal Dysplasia+1 more
CDx Diagnostics 3,173
Testing effectiveness (Phase 2)Ended earlyNCT00130936
What this trial is testing

Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates

Who this might be right for
Gastric CancerEsophageal CancerTumors
AHS Cancer Control Alberta 50
Not applicableEnded earlyNCT00767234
What this trial is testing

Permission to Collect Blood Over Time for Research

Who this might be right for
Pancreatic CancerGastrointestinal NeoplasmsColon Rectal Cancer Adenocarcinoma+11 more
Stanford University 104
Testing effectiveness (Phase 2)Study completedNCT03490292
What this trial is testing

Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer

Who this might be right for
Resectable Esophageal CancerGastroEsophageal Cancer
University of Wisconsin, Madison 22
Not applicableStudy completedNCT02699060
What this trial is testing

Experimental Study to Determine the Effects of Human Refluxate on Macrophage Phenotype and Its Correlation With GERD

Who this might be right for
Gastroesophageal Reflux Disease (GERD)
Ivashkin Vladimir Trofimovich 68
Testing effectiveness (Phase 2)Study completedNCT00086996
What this trial is testing

S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction

Who this might be right for
Esophageal Cancer
SWOG Cancer Research Network 98
Large-scale testing (Phase 3)Looking for participantsNCT07221149
What this trial is testing

Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Who this might be right for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Bristol-Myers Squibb 690
Testing effectiveness (Phase 2)Study completedNCT00439608
What this trial is testing

Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Brown University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06750185
What this trial is testing

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 248
Large-scale testing (Phase 3)Study completedNCT02853474
What this trial is testing

Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy

Who this might be right for
Gastric CancerPancreas CancerBile Duct Cancer+2 more
Centre Oscar Lambret 480
Testing effectiveness (Phase 2)Study completedNCT01388790
What this trial is testing

Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer

Who this might be right for
Gastric Cancer
Merck KGaA, Darmstadt, Germany 40
Early research (Phase 1)Ended earlyNCT04665921
What this trial is testing

SGN-STNV in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungHER2 Negative Breast NeoplasmsOvarian Neoplasms+9 more
Seagen Inc. 111
Not applicableStudy completedNCT05540145
What this trial is testing

Neo-Sequence 1: Neoadjuvant Chemotherapy With or Without Antiangiogenesis and Sequential Immunotherapy for HER2-negative MMR-proficient Locally Advanced Gastric or Gastroesophageal Adenocarcinoma

Who this might be right for
Gastric Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06764251
What this trial is testing

Tislelizumab Combined with SOX Regimen in the Treatment of Locally Advanced Gastric Cancer/gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric/Gastroesophageal Junction Adenocarcinoma
Liaoning Cancer Hospital & Institute 20
Not applicableEnded earlyNCT00737802
What this trial is testing

In Vivo Anatomy, Physiology, Mechanics and Function of the Lower Esophageal Sphincter

Who this might be right for
GERDBarretts Esophagus
Northwell Health 4
Testing effectiveness (Phase 2)Study completedNCT03647969
What this trial is testing

Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer

Who this might be right for
Adenocarcinoma of the StomachGastroEsophageal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 262
Next Page